ChemoMetec A/S (CHY) Stock Statistics & Valuation Metrics
Total Valuation
ChemoMetec A/S has a market cap or net worth of EUR 1.64B. The enterprise value is EUR 6.01B.
- Market Cap
- EUR 1.64B
- Enterprise Value
- EUR 6.01B
Share Statistics
ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 17,402,480
- Owned by Insiders
- ―
- Owned by Institutions
- 14.06%
Financial Efficiency
ChemoMetec A/S’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 23.74%.
- Return on Equity (ROE)
- 0.24
- Return on Assets (ROA)
- 0.20
- Return on Invested Capital (ROIC)
- 23.74%
- Return on Capital Employed (ROCE)
- 0.31
- Revenue Per Employee
- 2.34M
- Profits Per Employee
- 783.24K
- Employee Count
- 174
- Asset Turnover
- 0.60
- Inventory Turnover
- 0.34
Valuation Ratios
The current PE Ratio of ChemoMetec A/S is 50.42. ChemoMetec A/S’s PEG ratio is 2.10.
- PE Ratio
- 50.42
- PS Ratio
- 18.56
- PB Ratio
- 14.26
- Price to FCF
- 56.04
- Price to Operating Cash Flow
- 48.39
- PEG Ratio
- 2.10
Income Statement
In the last 12 months, ChemoMetec A/S had revenue of 407.87M and earned 136.28M in profits. Earnings per share was 7.83.
- Revenue
- 407.87M
- Gross Profit
- 367.60M
- Operating Income
- 178.78M
- Pretax Income
- 176.59M
- Net Income
- 136.28M
- EBITDA
- 186.59M
- Earnings Per Share (EPS)
- 7.83
Cash Flow
In the last 12 months, operating cash flow was 176.20M and capital expenditures -24.04M, giving a free cash flow of 152.17M billion.
- Operating Cash Flow
- 176.20M
- Free Cash Flow
- 152.17M
- Free Cash Flow per Share
- 8.75
Dividends & Yields
ChemoMetec A/S pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.78%
- Earnings Yield
- 1.98%
Stock Price Statistics
- Beta
- 0.60
- 52-Week Price Change
- -1.06%
- 50-Day Moving Average
- 73.05
- 200-Day Moving Average
- 56.78
- Relative Strength Index (RSI)
- 80.73
- Average Volume (3m)
- 54
Important Dates
ChemoMetec A/S upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 10, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
ChemoMetec A/S as a current ratio of 4.97, with Debt / Equity ratio of 0.73%
- Current Ratio
- 4.97
- Quick Ratio
- 3.76
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.56
- Interest Coverage Ratio
- 976.96
Taxes
In the past 12 months, ChemoMetec A/S has paid 40.30M in taxes.
- Income Tax
- 40.30M
- Effective Tax Rate
- 0.23
Enterprise Valuation
ChemoMetec A/S EV to EBITDA ratio is 37.60, with an EV/FCF ratio of 54.35.
- EV to Sales
- 18.00
- EV to EBITDA
- 37.60
- EV to Free Cash Flow
- 54.35
- EV to Operating Cash Flow
- 46.94
Balance Sheet
ChemoMetec A/S has EUR 264.74M in cash and marketable securities with EUR 7.78M in debt, giving a net cash position of EUR 256.96M billion.
- Cash & Marketable Securities
- EUR 264.74M
- Total Debt
- EUR 7.78M
- Net Cash
- EUR 256.96M
- Net Cash Per Share
- EUR 14.77
- Tangible Book Value Per Share
- EUR 26.71
Margins
Gross margin is 91.07%, with operating margin of 48.79%, and net profit margin of 36.79%.
- Gross Margin
- 91.07%
- Operating Margin
- 48.79%
- Pretax Margin
- 47.96%
- Net Profit Margin
- 36.79%
- EBITDA Margin
- 47.87%
- EBIT Margin
- 45.77%
Analyst Forecast
The average price target for ChemoMetec A/S is EUR 66.62, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 66.62
- Price Target Upside
- 28.94% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- 3.00%
- EPS Growth Forecast
- 8.18%
